LINDAHL RICHARD S 4

What Happened

• Richard S. Lindahl, Chief Financial Officer of Emergent BioSolutions (EBS), had 3,964 shares withheld on 2026-06-08 to satisfy tax withholding obligations tied to the vesting/settlement of restricted stock units. The withholding was recorded at $8.00 per share, a total value of $31,712. This is a tax-related disposition (not an open-market sale) and is generally a routine administrative event.

Key Details

• Transaction date: 2026-06-08; Filing date: 2026-06-10 (filed within the typical two-business-day window).
• Transaction type/code: F — shares withheld to pay taxes associated with vesting/settlement of RSUs.
• Shares disposed: 3,964 at $8.00 each; total value $31,712.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: F1 — Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units.

Context

• This was a share-withholding (cashless/net settlement) to cover tax liabilities from RSU vesting, not a signal of a market sale or purchase. Such withholdings are common following equity awards and do not necessarily indicate a change in insider sentiment.